Dornan T L, Rhymes I L, Cederholm-Williams S A, Rizza C R, Pepys M B, Bron A J, Turner R C
Eur J Clin Invest. 1983 Jun;13(3):231-5. doi: 10.1111/j.1365-2362.1983.tb00093.x.
Plasma coagulation factors were measured in twelve male insulin-dependent diabetics with no retinopathy, ten with background and ten with proliferative retinopathy and ten non-diabetics. Factor VIII pro-coagulant activities (VIII:C), ristocetin cofactor activities and factor VIII-related antigen concentrations (VIIIR:ag) were significantly related to the severity of diabetic retinopathy (P less than 0.025, trend test). The mean ratio of VIII:C/VIIIR:ag was lower in the diabetics with proliferative retinopathy than in the other groups of diabetics (P less than 0.05) or the controls (P less than 0.02). Concentrations of alpha 2 macroglobulin and alpha 1 antitrypsin were highest in diabetics with proliferative retinopathy (0.1 greater than P greater than 0.05, trend test) but mean prothrombin and activated partial thromboplastin times and mean concentrations of alpha 2 antiplasmin, plasminogen activator and antithrombin III were similar in all groups. Concentrations of the platelet-specific protein beta thromboglobulin, though higher in diabetics than controls (P less than 0.005), were not related to retinopathy. The plasma concentrations of coagulation factors did not correlate with creatinine clearance and there were no significant differences between groups in concentrations C-reactive protein; this suggests that the raised concentrations of coagulation factors in diabetics with retinopathy were not a result of associated nephropathy or an 'acute phase protein' response to diabetic tissue damage. Increased coagulation activity in diabetics may contribute to the development of retinopathy.
对12名无视网膜病变的男性胰岛素依赖型糖尿病患者、10名有背景性视网膜病变的患者、10名有增殖性视网膜病变的患者以及10名非糖尿病患者测定了血浆凝血因子。因子VIII促凝血活性(VIII:C)、瑞斯托霉素辅因子活性以及因子VIII相关抗原浓度(VIIIR:ag)与糖尿病视网膜病变的严重程度显著相关(P<0.025,趋势检验)。增殖性视网膜病变糖尿病患者的VIII:C/VIIIR:ag平均比值低于其他糖尿病组(P<0.05)或对照组(P<0.02)。α2巨球蛋白和α1抗胰蛋白酶浓度在增殖性视网膜病变糖尿病患者中最高(0.1>P>0.05,趋势检验),但所有组的平均凝血酶原时间和活化部分凝血活酶时间以及α2抗纤溶酶、纤溶酶原激活剂和抗凝血酶III的平均浓度相似。血小板特异性蛋白β血小板球蛋白的浓度虽然在糖尿病患者中高于对照组(P<0.005),但与视网膜病变无关。凝血因子的血浆浓度与肌酐清除率无相关性,各组间C反应蛋白浓度无显著差异;这表明视网膜病变糖尿病患者凝血因子浓度升高不是相关肾病或对糖尿病组织损伤的“急性期蛋白”反应的结果。糖尿病患者凝血活性增加可能有助于视网膜病变的发展。